Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxotere Plus Weekly Navelbine and G-CSF in Stage IV Breast Cancer
NCT00194740Phase 2Completed
- Sponsor
- University of Washington
- Start
- Nov 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and vinorelbine in breast cancer, sponsored by University of Washington. Primary endpoints: Response to treatment and Toxicity of treatment. Started Nov 1997; status: completed.
02
Drugs
docetaxelvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00194740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194740.